← back to dashboard

BRTX

BioRestorative Therapies, Inc.
Composite
0.35
EDGAR
0.35
Filings (90d)
4
Peak
0.37
Last Signal
2026-06-12T17:00

All Filings

Filed Form Items Signal Score Summary Link
2026-06-12 17:00 8-K ["5.02", "9.01"] officer change 0.15 Routine employment agreement extension for VP R&D; no M&A indicators present. SEC · detail
2026-06-12 16:56 8-K ["1.01", "5.02"] material agreement 0.72 Lender Bowery Group LLC gains board control via revolving loan agreement with director replacement provisions—potential distressed M&A signal. SEC · detail
2026-05-29 17:07 8-K ["5.02", "5.07", "9.01"] officer change 0.52 CEO/CFO multi-year employment agreements + 20x authorized share increase suggest capital raise or M&A preparation. SEC · detail
2026-05-01 16:17 8-K ["5.02"] other 0.05 Routine executive compensation disclosure; no M&A signals present. SEC · detail